RYANODEX DANTROLENE SODIUM
Generic: DANTROLENE SODIUM
Eagle PharmaceuticalsManufacturer
INTRAVENOUSRoute
DANTROLENE SODIUMActive Substance
2014-07-22Original Approval
RYANODEX DANTROLENE SODIUM is FDA application NDA205579, sponsored by EAGLE PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
NEUROLEPTIC MALIGNANT SYNDROME
44 reports
2
RESPIRATORY FAILURE
35 reports
3
DRUG INEFFECTIVE
31 reports
4
MUSCULAR WEAKNESS
29 reports
5
ASTHENIA
28 reports
6
PYREXIA
28 reports
7
CONVULSION
26 reports
8
DIARRHOEA
26 reports
9
VOMITING
21 reports
10
FATIGUE
19 reports